Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 28.95
-0.05 (-0.17%)
Aug 13, 2025, 1:30 PM CST
Apex Biotechnology Market Cap
Apex Biotechnology has a market cap or net worth of 2.90 billion as of August 13, 2025. Its market cap has decreased by -14.45% in one year.
Market Cap
2.90B
Enterprise Value
2.34B
Revenue
2.03B
Ranking
n/a
PE Ratio
18.00
Stock Price
28.95
Market Cap Chart
Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 2.90B, an increase of 103.41%. That is a compound annual growth rate of 3.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 2.89B | -3.82% |
| Dec 31, 2024 | 3.01B | -25.31% |
| Dec 29, 2023 | 4.03B | 57.73% |
| Dec 30, 2022 | 2.55B | -1.73% |
| Dec 30, 2021 | 2.60B | 10.38% |
| Dec 31, 2020 | 2.35B | -16.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 207.84B |
| PharmaEssentia | 167.97B |
| Bora Pharmaceuticals Co., LTD. | 90.60B |
| Lotus Pharmaceutical | 54.57B |
| Oneness Biotech | 30.94B |
| Polaris Group | 27.70B |
| Center Laboratories | 26.60B |
| Lumosa Therapeutics | 25.91B |